CTOs on the Move

Perry Thomas Ford Mercury

www.rxccars.com

 
Perry Thomas Ford Mercury is a Shelbyville, IL-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.rxccars.com
  • 401 N Cedar St
    Shelbyville, IL USA 62565
  • Phone: 217.774.2191

Executives

Name Title Contact Details

Similar Companies

Securities Service Network

Based in Knoxville, Tennessee, Securities Service Network, Inc. is an independent broker dealer supporting over 400 independent financial advisory practices and approximately $13 billion in advisory and brokerage client assets. SSN provides a range of back and middle office services that drive the success of independent financial advisors, balanced with a longstanding commitment to empower independent advisors to reinvest in their own businesses by providing industry-leading payouts. Founded in 1983 as one of the nation`s first fee-based, independent broker-dealers, SSN was acquired by Ladenburg Thalmann Financial Services Inc. (NYSE MKT: LTS) in 2015 and became a member of its family of independent broker-dealers. In 2016, SSN was honored, for the fourth year in a row, as one of the Top Independent BDs, as rated by financial advisors, on WealthManagement.com, a leading industry media outlet.

Ratner Property Management

Ratner Property Management provides information on market trends, news, marketing tips and operational strategies for real Estate professionals.

Life Settlement Leads

Life Settlement Leads is a Parsippany, NJ-based company in the Business Services sector.

Arzee Supply Corp of New

Wholesale distributors of roofing siding and building materials in New Jersey.

AmpliPhi Biosciences

AmpliPhi Biosciences Corporation (NYSEMKT: APHB) is a biotechnology company focused on the development and commercialization of novel bacteriophage-based antibacterial therapeutics. AmpliPhi`s product development programs target infections that are often resistant to existing antibiotic treatments. AmpliPhi is collaborating with a number of leading organizations, including Intrexon Corporation (NYSE: XON), the U.S. Army, The Royal Brompton Hospital in London, UK and UK-based University of Leicester, to rapidly advance bacteriophage-based therapies.